Buffered creatine is creatine with an alkaline powder added, sold on the claim that a higher pH stops it breaking down to creatinine in the stomach, so that 1.5 g can do the work of 10–15 g. The one head-to-head trial that measured muscle (Jagim et al., 2012, 36 trained men) found no greater rise in muscle creatine, and no better training outcomes, than creatine monohydrate at either dose.
That is a small finding from a small trial, and the chemistry makes it smaller still for the buffer. The breakdown it is sold to stop barely happens in the first place, because stomach acid already stops it. What follows takes the claim apart in the order it is made — the pH, the dose, the muscle, the side effects — with the number each part rests on.
What is buffered creatine?
It is creatine with an alkaline powder mixed in to raise its pH. The 2012 trial describes the product's patent: an alkaline powder, with soda ash, bicarbonate and magnesium glycerol phosphate given as examples, adjusts the pH to somewhere between 7 and 14. Alkaline creatine and pH-correct creatine are the same pitch under other names. The molecule doing the work is still creatine; the buffer is the addition, and it is sold as the reason a smaller dose is enough.
The claims, as Jagim and colleagues list them from the product's own marketing, come in four parts: that it stays stable in the stomach instead of turning into creatinine, that more of it reaches the muscle, that 1.5 g matches roughly 10–15 g of ordinary creatine, and that it spares the user the bloating and cramping blamed on monohydrate. Writing in 2012, the authors could find no peer-reviewed study supporting any of the four. Each one is a measurable statement, which is the useful thing about it.
The same verdict appears in the NIH Office of Dietary Supplements' fact sheet on supplements for exercise, which groups buffered creatine with creatine ethyl ester as forms that have not shown an advantage over monohydrate.
Does stomach acid break down creatine monohydrate?
Barely, and the acid is the reason. Creatine becomes creatinine by folding in on itself in solution, a reaction that speeds up as pH falls — but only down to a point. Below pH 2.5 the molecule picks up a proton that blocks the fold. The 2017 ISSN creatine position stand (Kreider et al.) concludes that conversion in the gut “is minimal regardless of transit time” and that absorption into the blood is “nearly 100%”.
The figures usually quoted for creatine breaking down are real, and they describe something else. Kept in solution at 25 degrees Celsius for three days, creatine converted to creatinine at 4% at pH 5.5, 12% at pH 4.5 and 21% at pH 3.5, and was fairly stable at pH 6.5 to 7.5 — the same position stand prints all of them. Those numbers are why creatine is sold as a powder and why a creatine drink should not stand for days. They are not a measurement of a stomach, which holds a dose for hours rather than days.
The same paragraph of the position stand carries the detail that undoes the buffer's premise. The reaction can be slowed or halted by pushing the pH below 2.5 or by raising it. Raising it is the buffer's theory. The stomach gets there first by going the other way.
The closest thing to a stomach measurement is also the weakest number on this page. A 2007 conference abstract, summarised in the 2012 trial's introduction, found under 1% of creatine monohydrate converted to creatinine at pH 1 and body temperature, and more conversion from the buffered product under similar conditions. It was never published in full. It points the same way as the chemistry, and it is cited here as an abstract, not as a paper.
Does buffered creatine work better than creatine monohydrate?
Not in the only trial that measured it in muscle. Jagim and colleagues (2012) gave 36 resistance-trained men one of three regimens for 28 days: monohydrate at 20 g a day for 7 days and then 5 g a day; buffered creatine at its label dose of 1.5 g a day; or buffered creatine at the monohydrate doses. Muscle creatine rose over the 28 days with no significant difference between the three arms, and bench press, sprint power and body composition moved alike in all of them.
The numbers behind that null lean one way, and they are worth seeing. Change in unbound muscle creatine at day 28, in millimoles per kilogram of dry muscle, from the paper's Table 6: monohydrate +22.3, buffered at the matched dose +9.1, buffered at the label dose +4.7. Only 25 men had usable biopsies at both ends — 8 or 9 per arm — and the standard deviations ran from 21 to 27, which is why a gap that size could not reach significance (group by time, p = 0.46). The direction favours monohydrate. The trial was too small to say more than that, and this page will not say more than that either.
| The claim | What was measured | Source |
|---|---|---|
| A higher pH stops creatine turning into creatinine in the stomach | Below pH 2.5 the reaction is already slowed or halted; gut conversion is “minimal regardless of transit time” | ISSN creatine position stand, 2017 |
| 1.5 g does the work of 10–15 g of monohydrate | 1.5 g a day for 28 days: unbound muscle creatine +4.7 mmol/kg dry muscle, against +22.3 for monohydrate | Jagim et al., 2012 |
| More of it reaches the muscle | At the monohydrate doses: +9.1 against +22.3; no significant difference between arms | Jagim et al., 2012 |
| Better training outcomes | Bench press and 30-second sprint power rose in every arm, with no difference between arms; leg press changed in none | Jagim et al., 2012 |
| Fewer side effects | No side effects reported in any arm; serum creatinine rose with dose in all three, within the normal range for active people | Jagim et al., 2012 |
Does a smaller dose of buffered creatine work?
The label says 1.5 g a day equals 10–15 g of ordinary creatine. The 2012 trial put exactly that dose up against monohydrate, and it produced the smallest change of the three arms: unbound muscle creatine up 4.7 mmol/kg of dry muscle at day 28, against 22.3 for monohydrate. Across the 28 days the label-dose group took 42 g of product and the monohydrate group 245 g of creatine monohydrate. Nothing in the data suggests the buffer closed that gap.
For scale, the ISSN creatine stand puts the creatine a body has to replace each day at about 1–3 g, roughly half of it from an ordinary diet. A 1.5 g serving sits inside that daily replacement range — under the 3–5 g a day the same stand gives for holding stores up once they are full, and far under the roughly 20 g a day used to fill them inside a week.
Does buffered creatine cause fewer side effects?
There was nothing to improve on. In the 2012 trial no participant in any arm reported a side effect, so the comparison the claim needs never had anything to compare. Serum creatinine rose in all three groups, more at the higher doses, and stayed within the normal range for active people. Where creatine does upset a stomach, the usual cause is a large single dose, and a buffer does not change the size of a dose.
Where creatine side effects actually come from — water, one hormone study and a blood-test number — is set out in creatine side effects, including why a creatinine reading rises on any creatine and what to tell whoever orders the test.
Should you buy buffered creatine or creatine monohydrate?
Creatine monohydrate. It is the form the ISSN's dosing figures were built on, the one head-to-head trial found no advantage for the buffered version at either dose, and the chemistry the buffer is sold on works against it. If a buffered product's serving carries less creatine than a 3–5 g monohydrate serving, the label is asking the buffer to do work no trial has seen it do.
The label check is the same one that settles creatine HCl against monohydrate: find the creatine compound and its milligram figure, divide by the compound's creatine fraction — monohydrate is 87.9% creatine by weight, by the 2011 review of novel creatine forms — and compare grams of creatine, not scoops. An alkaline additive is part of the scoop and none of the creatine. The terms a creatine panel uses are defined in the supplement label glossary, and the daily numbers are in how much creatine per day.
What the research does not show
One trial is not a literature, and this one is small. It had 36 men with an average age of 20, four weeks of supplementation and 25 usable pairs of biopsies. It measured the unbound creatine in muscle and set aside phosphocreatine — about two thirds of the creatine in muscle, by the ISSN's figure — because that assay gave values outside normal ranges. With 8 or 9 men per arm and that much spread, a real difference could be missed in either direction: a null in a sample this size is weak evidence of sameness.
It was also paid for by a manufacturer of creatine monohydrate, which funded the work through a research grant to Texas A&M University and supplied the study's capsules; the authors state that they had no financial interest in the outcome. The funding points the same way as the finding, which is a reason to want a second trial. A 2026 audit in Nutrients of 343 randomised creatine trials published between 1994 and 2023 found five, 1.5%, that compared one creatine formulation with another at all, and recorded that those few were frequently limited by unequal dosing.
Nothing here speaks to men over 45 or to months of use: the volunteers were college-age and the trial ran 28 days. And the degradation argument is thinner on both sides than it sounds. The buffered product's stability claims had no peer-reviewed support when the trial was written up; the counter-finding that the buffered product converts more creatine to creatinine is a conference abstract. What rests on published chemistry is the mechanism: strong acid blocks the reaction.
Where Base Work sits. Base Work is creatine monohydrate and nothing else — one ingredient, unflavoured, 300 g, 5 g a day, 60 servings — with no buffer and no claim that a smaller scoop does more. The raw material was measured by an independent laboratory (Ethos Analytics, for Vox Nutrition; raw-material lot CM20251225A; the powder made by Accobio USA Inc.) at 99.87% creatine monohydrate against a greater-than-99.5% specification. That certificate covers raw material, not a finished TARE tub, and what it does and does not cover is set out on the testing page. Base Work does not ship to New York addresses; the reason is in the shipping policy.
More in this cluster: every supplement form we compare, side by side, creatine ethyl ester vs monohydrate, micronized creatine vs monohydrate, the creatine research summary and how to choose a creatine supplement.
Sources
- Jagim AR, Oliver JM, Sanchez A, et al. J Int Soc Sports Nutr 2012;9(1):43. PubMed 22971354
- Kreider RB, Kalman DS, Antonio J, et al. J Int Soc Sports Nutr 2017;14:18. PubMed 28615996
- Jager R, Purpura M, Shao A, Inoue T, Kreider RB. Amino Acids 2011;40(5):1369-1383. PubMed 21424716
- Bucevic Popovic V, Sovulj A, Raic S, et al. Nutrients 2026;18(16):2697. PubMed 42654277
- NIH Office of Dietary Supplements. Dietary Supplements for Exercise and Athletic Performance: Fact Sheet for Health Professionals. NIH Office of Dietary Supplements